ADRIATIC Trial Shows Durvalumab as Promising Treatment for Small Cell Lung Cancer
Dr. Julie Gralow presents interim results of the ADRIATIC trial at the 2024 Plenary Session, focusing on durvalumab as a consolidation treatment for limited-stage small cell lung cancer. Results show significant improvements in overall survival and progression-free survival compared to standard care, potentially changing clinical practice in this field.
AstraZeneca Withdraws Oxford-AstraZeneca Covid Vaccine Worldwide
The Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide due to a rare and dangerous side effect, leading to its discontinuation in the European Union and other countries. AstraZeneca cited commercial reasons and the availability of newer alternatives as the primary drivers behind this decision. Despite saving over six million lives, the vaccine has faced scrutiny for causing blood clots and low blood platelet counts, resulting in legal action from affected individuals and families.
Man Dies After Receiving Fatal Covid Jab Due to GP Data Error
A coroner issues a warning after a 28-year-old man dies following a fatal Covid jab due to a GP data error. The man, wrongly classified as morbidly obese, received the Oxford AstraZeneca vaccine at a younger age than recommended, leading to his untimely death. This tragic incident underscores the critical need for accurate health service data to prevent similar errors and save lives.
AstraZeneca admits Covid vaccine can cause rare side effect in court documents
AstraZeneca has admitted in court documents that its Covid vaccine can cause a rare side effect, Thrombosis with Thrombocytopenia Syndrome (TTS). This admission comes amid a class-action lawsuit alleging serious injury and death. The legal battle began with Jamie Scott, who suffered a permanent brain injury after vaccination. AstraZeneca’s acknowledgment could lead to substantial financial compensation for affected individuals, with fifty-one cases pending in the High Court seeking damages of £100 million.